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Genetic investigation of crescentic glomerulonephri-
tis (Crgn) susceptibility in the Wistar Kyoto rat, a
strain uniquely susceptible to nephrotoxic nephritis
(NTN), allowed us to positionally clone the activator
protein-1 transcription factor Jund as a susceptibility
gene associated with Crgn. To study the influence of
Jund deficiency (Jund-/-) on immune-mediated renal
disease, susceptibility to accelerated NTN was exam-
ined in Jund-/- mice and C57BL/6 wild-type (WT) con-
trols. Jund-/- mice showed exacerbated glomerular
crescent formation and macrophage infiltration, 10
days after NTN induction. Serum urea levels were also
significantly increased in the Jund-/- mice compared
with the WT controls. There was no evidence of im-
mune response differences between Jund-/- and WT
animals because the quantitative immunofluores-
cence for sheep and mouse IgG deposition in glomer-
uli was similar. Because murine Jund was inactivated
by replacement with a bacterial LacZ reporter gene,
we then investigated its glomerular expression by
IHC and found that the Jund promoter is mainly ac-
tive in Jund-/- podocytes. Furthermore, cultured glom-
eruli from Jund-/- mice showed relatively increased
expression of vascular endothelial growth factor A
(Vegfa), Cxcr4, and Cxcl12, well-known HIF target
genes. Accordingly, small-interfering RNA–mediated
JUND knockdown in conditionally immortalized hu-
man podocyte cell lines led to increased VEGFA and
HIF1A expression. Our findings suggest that defi-
ciency of Jundmay cause increased oxidative stress in
podocytes, leading to altered VEGFA expression and
134subsequent glomerular injury in Crgn. (Am J Pathol
2011, 179:134–140; DOI: 10.1016/j.ajpath.2011.03.006)
JunD is a ubiquitously expressed DNA-binding protein,
one of the components of the activator protein-1 (AP-1)
transcription factor. AP-1 members are dimeric com-
plexes composed of Jun (c-Jun, JunB, v-Jun, and JunD),
Fos (c-Fos, FosB, Fra-1, and Fra-2), and ATF (ATF1-4,
ATF-6, -ATF, and ATFx) proteins. AP-1 can either acti-
vate or repress transcription, depending on the specific
components of the complex and the cellular environ-
ment.1 Jund expression and JunD protein-protein inter-
actions modulate tumor angiogenesis, cellular differenti-
ation, proliferation, and apoptosis.1,2 An additional
function of Jund in the control of oxidative stress and
angiogenic switch was recently discovered.3–5 Moreover,
Jund-mediated oxidative stress has played a pivotal role
in systemic regulation of insulin that affects lifespan6 and
in tumor development by altering the microenvironment.7
Glomerulonephritis is a major cause of kidney failure in
humans. Crescentic glomerulonephritis (Crgn) is the
most severe form and may be seen with immune complex
deposition in glomeruli, with antibodies directed against
the glomerular basement membrane, or in systemic vas-
culitis. Well-documented variation in susceptibility to
Crgn between inbred strains of rodents has strongly sug-
gested the influence of genetic predisposing factors in
animal models.8–12 The rat nephrotoxic nephritis (NTN)
model leads to severe Crgn in the Wistar Kyoto (WKY) rat,
whereas the Lewis rat that shares the same major histo-
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This model is highly reproducible and heritable, and the
increased genetic susceptibility of the WKY rat is ex-
plained by both circulating and renal intrinsic factors.10,14
By using genomewide linkage and glomerular expression
analyses in NTN-susceptible WKY and Lewis rats, Jund
was previously positionally cloned as a susceptibility
gene associated with Crgn.9 Jund is markedly overex-
pressed in the NTN-susceptible WKY glomeruli and bone
marrow–derived macrophages (BMDMs) in basal condi-
tions. Small-interfering RNA (siRNA)–mediated Jund
knockdown in WKY BMDMs led to decreased macro-
phage activation, suggesting a novel role for Jund in
macrophage activation,9 an important hallmark of the
pathophysiological features of glomerulonephritis. Al-
though Jund is not differentially expressed between WKY
and Lewis mesangial cells, our microarray analysis
showed that it was markedly overexpressed in the basal
(without NTN induction) and nephritic WKY glomeruli 10
days after nephrotoxic serum (NTS) injection.9 This find-
ing suggests that Jund expression by glomerular, other
than mesangial, cells contributes to glomerular crescent
formation. To elucidate the cellular mechanisms by which
Jund contributes to glomerular inflammation, we studied
the effect of targeted deletion of Jund in the accelerated
NTN model in the mice.
Herein, we report that Jund-deficient (Jund-/-) mice
show exacerbated glomerular crescent formation, 10
days after NTN induction, with significantly increased
serum urea levels when compared with WT controls. We
show that Jund promoter is mainly active in Jund-/- podo-
cytes and that cultured glomeruli from Jund-/- mice
showed increased expression of vascular endothelial
growth factor A (Vegfa), Cxcr4, and Cxcl12. Consistent
with these findings, siRNA-mediated JUND knockdown in
conditionally immortalized human podocyte cell lines led
to increased VEGFA and HIF1A expression, suggesting
that deficiency of Jund may cause increased oxidative
stress in podocytes, leading to glomerular injury in Crgn.
Materials and Methods
Mice
The Jund-/- colony was maintained through the breeding
of heterozygous animals on a C57BL/6–129 mixed ge-
netic background. Because male Jund-/- mice were pre-
viously reported to be sterile,15 6- to 10-week-old Jund-/-
and wild-type (WT) female littermates were used in all
procedures. Genotyping was performed from mice tail
snips by using Jund- and LacZ-specific primers, as pre-
viously described.15 All mice were housed with free ac-
cess to food and water, according to institutional guide-
lines.
Induction of Accelerated NTN
Nephrotoxic globulin was prepared as previously de-
scribed.16 Briefly, a sheep was immunized with murine
glomerular lysate initially in complete and then incom-
plete Freund’s adjuvant (Sigma, Dorset, UK). After am-monium sulfate precipitation, a -globulin–enriched frac-
tion of immune serum was heat inactivated. The
precipitate was extensively dialyzed against sterile PBS
(Invitrogen, Paisley, UK) and stored at -80°C. The endo-
toxin content of the nephrotoxic globulin was undetect-
able after using a Biowhittaker QCL-1000 LPS assay kit
(Biowhittaker, Walkersville, MD). Mice were immunized
i.p. with 0.2 mg of sheep IgG in a v/v mix with complete
Freund’s adjuvant (Sigma). Five days after the immuniza-
tion, 5 mg of NTS was injected i.v. to WT and Jund-/- mice
(n  10 per group). The mice were monitored clinically;
10 days after NTS injection, the mice were anesthetized
with i.p. midazolam and fentanyl and exsanguinated be-
fore harvesting the kidneys. Serum was also collected
from all mice on day 10 for urea nitrogen determination as
an indicator of renal function.
Renal Function Assessment
The serum urea concentration was measured using an
assay based on the hydrolysis of urea to ammonium and
subsequent oxidization of NADH, according to the man-
ufacturer’s instructions (R-biopharm, Glasgow, UK). Se-
rum albumin levels were assessed by a mouse albumin
enzyme-linked immunosorbent assay (Cambridge Bio-
science, Cambridge, UK) that uses a competitive en-
zyme immunoassay with a polyclonal antibody specific
for mouse albumin.
Histological Studies and Quantitative
Immunofluorescence
Kidneys were fixed in 10% formal saline, processed, em-
bedded in paraffin wax, and stained with Periodic acid-
Schiff reagent. Glomeruli were assessed for histological
abnormalities on a semiquantitative scale from 0 to 4,
where 0 is normal; 1 and 2, glomerular tuft hypercellular-
ity; and 3 and 4, glomerular tuft hypercellularity with cres-
cents. Glomerular crescents were defined as glomeruli
containing two or more layers of cells in the Bowman’s
space. One hundred glomeruli were counted per sample,
and results are presented as percentage of glomerular
crescents.
For immunofluorescence, kidneys were embedded in
OCT (Cellpath, Newtown, UK), snap frozen in isopentane
cooled with liquid nitrogen, and stored at 80°C. Sec-
tions (5-m thick) were fixed in acetone-methanol for 10
minutes.
Glomerular mouse and sheep IgG was visualized by
direct immunofluorescence using fluorescein isothiocya-
nate (FITC)–conjugated goat anti-mouse IgG (Fc specific)
and FITC–conjugated monoclonal mouse anti-sheep IgG
clone GT34 (Sigma).
Glomerular C3 staining was assessed by direct immuno-
fluorescence using a FITC–conjugated goat anti-mouse C3
IgG (MP Biomedicals, Cambridge, UK), as previously de-
scribed.17 To quantitate immunofluorescence, sections
were examined at 100 magnification using an Olympus
BX4 fluorescence microscope (Olympus Optical, London,
UK) and a Photonic Science Color Coolview camera (Pho-
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periment were stained on the same occasion and mea-
sured together. Images of the sections were captured by
the image analysis equipment, and the total pixel intensity
for each glomerulus was measured and averaged for 20
glomeruli per section. The arbitrary units of fluorescence
correspond to the mean pixel intensity for 20 glomeruli for
each mouse.
For immunoperoxidase staining of macrophages,
snap-frozen 5-m kidney sections were stained with
FA11 (monoclonal rat anti-mouse CD68; AbD Serotec,
Kidlington, UK). Polyclonal biotinylated rabbit anti-rat IgG
was used as a secondary antibody (Stratech, Newmarket
Suffolk, UK). Peroxidase-conjugated avidin-biotin com-
plex (Vector Laboratories, Peterborough, UK) reagent
was used to detect specific CD68 staining in the renal
cortex.
For -galactosidase IHC, paraffin sections were sub-
jected to antigen retrieval by trypsin digestion for 10 min-
utes. The primary antibody was anti– galactosidase (Pro-
mega Z378A) at 1:1000, and binding was detected using a
Biogenex polymer horseradish peroxidase detection kit.
Splenocyte Proliferation
For splenocyte proliferation, spleens were harvested 7 days
after immunization with sheep IgG. After the preparation of
single-cell suspensions and red blood cell lysis, cells were
cultured at 1  106 cells/mL for 72 hours in HL1 serum-free
medium (Lonza, Slough, UK), in the presence or absence of
100 g/mL heat-aggregated sheep IgG or 2 million CD3/
CD28Dynabeads (Invitrogen) per well as a positive control. At
72 hours, 1 Ci/well 3H thymidine was added for 24 hours
before assessing splenocyte proliferation using aWallac 1450
MicroBeta counter.
ELISA for IgG Subclasses
The level of serum IgG subclasses was determined by
enzyme-linked immunosorbent assay using goat anti-
mouse IgG1, IgG2a, IgG2b, and IgG3 (Southern Biotech,
Birmingham, AL). Briefly, Nunc plates precoated with 100
g/mL sheep IgG (Sigma) were blocked and then incu-
bated with serum collected after NTN induction at differ-
ent dilutions (1:1000 for IgG1 and 1:500 for IgG2a,
IgG2b, and IgG3). After adding goat anti-mouse IgG
conjugated to alkaline phosphatase (Southern Biotech),
antibody binding was detected using p-nitrophenyl phos-
phate substrate (Sigma) at an OD of 405.
Glomerular Gene Expression Analysis
Glomeruli were sieved from the cortex of WT and Jund-/-
kidneys, as previously described.18 Total RNA was ex-
tracted from sieved glomeruli of unmanipulated or NTN-
induced Jund-/- mice and WT littermates by using the
TRIzol method. Vegfa, Hif1a, Cxcr4, Cxcl12, fibronectin,
c-Jun, and c-Fos expression levels were determined by
quantitative RT-PCR (RT-qPCR) using forward and re-
verse primers, as follows: mouse Vegfa, 5=-TGTGATTCT-
GATAAAATAGACATTGC-3= (forward) and 5=-TTTTTC-CCCCACAATTATTACG-3= (reverse); mouse Hif1a, 5=-
CCCATACAAGGCAGCAGAAA-3= (forward) and 5=-
AGCCACCAGTGTCCAAAAAT-3= (reverse);Cxcr4, 5=-CCT-
CAGCTGTTGCTGCATAA-3= (forward) and 5=-CACCAT-
TTCAGGCTTTGGTT-3= (reverse); Cxcl12, 5=-CAGAGCCA-
ACGTCAAGCA-3= (forward) and 5=-AGGTACTCTTGG-
ATCCAC-3= (reverse); fibronectin, 5=-GCGACTCTGACTGGC-
CTTAC-3= (forward) and 5=-CCGTGTAAGGGTCAAAGCAT-3=
(reverse); c-Jun, 5=-TGTCCTGCCCAGTGTTTGTA-3= (for-
ward) and5=-GAGGTTGGGGGCTACTTTTC-3= (reverse); and
c-Fos, 5=- CCAGTCCTCACCTCTTCCAG-3= (forward) and 5=-
TCCAGCACCAGGTTAATTCC-3= (reverse).
Human Podocyte Culture and siRNA
Knockdown
Conditionally immortalized human podocytes were a gift
from Moin Saleem (University of Bristol, Bristol, UK).
These podocytes were derived by incorporating a tem-
perature-sensitive SV40 gene that enables cells to prolif-
erate at the permissive temperature (33°C) and to differ-
entiate at the nonpermissive temperature (37°C). The
characteristics of the WT human podocyte cell line were
previously reported.19 Cells were cultured for 14 days at
the nonpermissive temperature (37°C) in 6 well plates
(Nunc) in RPMI 1640 medium with glutamine (Invitrogen,
Paisley, UK), supplemented with 10% fetal calf serum
(Biosera, East Sussex, UK) and 1% insulin transferrin
sodium selenite (Sigma). siRNA knockdown experiments
were performed as previously described.9 JUND knock-
down and the effect of its knockdown on VEGFA and
HIF1A expression were assessed by RT-qPCR by using
forward and reverse primers, as follows: JUND, 5=-CT-
CAAGGACGAGCCACAGAC-3= (forward) and 5=-
GGGTCTTCACTTTCTCTTCCA-3= (reverse); human VEGFA,
5=-TCCTCACACCATTGAAACCA-3= (forward) and 5=-
TTTTCTCTGCCTCCACAATG-3= (reverse); and human
HIF1A, 5=-GGGAGTTTATCCCTTTTTCG-3= (forward) and
5=-TTGTGGCTACCACGTACTGC-3= (reverse).
BMDM Culture, Fc OxyBURST, and
Phagocytosis Assays
Femurs from adult Jund-/- and WT mice were isolated and
flushed with HBSS. Total BM-derived cells were plated
and cultured for 7 days, as previously described.10 For
the Fc oxyBURST assay, 106 BMDMs (in triplicate) were
suspended in Krebs’ Ringer PBS with 1.0 mmol/L Ca2,
1.5 mmol/L Mg2, and 5.5 mmol/L glucose; warmed to
37°C; and stimulated with Fc oxyBURST reagent (240
g/mL; Invitrogen). Individual data points consisting of
10,000 fluorescence events were collected at 0, 15, 45,
75, 90, 105, and 120 seconds in an FACSCalibur after a
baseline fluorescence reading was taken to determine
the intrinsic fluorescence of unstimulated cells. The per-
centage of fluorescence BMDMs corresponds to the per-
centage of activated gated cells after Fc receptor–medi-
ated phagocytosis. Jund-/- and WT BMDMs were also
assessed for phagocytosis, as previously described.9Briefly, latex polystyrene 6.0-mmicrospheres (50 beads
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were opsonized with bovine serum albumin–anti–bovine
serum albumin IgG (Sigma) and added to macrophages
cultured in eight-well glass chamber slides. After staining
with Diff-Quick fix (Dade Behring, Newark, DE), 100 mac-
rophages were counted to determine the number of
beads ingested per cell.
Statistics
Results describing glomerular injury and immune re-
sponse are expressed as median (range). All RT-qPCR
results and the assessment of glomerular CD68 and
CD4 cells are expressed as mean SE. Nonparametric
tests of significance were applied throughout. For com-
paring two groups, the Mann-Whitney U-test was used and
differences were considered significant when P  0.05.
Results
Targeted Jund Deletion and Susceptibility to
Crgn in Mice
Jund-/- mice showed marked susceptibility to Crgn on day
10 after the induction of accelerated NTN when compared
with age- and sex-matched WT littermates (Figure 1, A–C).
All of the WT mice showed glomerular abnormalities, rang-
ing from mild segmental glomerular hypercellularity to oc-
casional crescents. However, there was a marked increase
in the glomerular hypercellularity and crescent formation in
the Jund-/- mice when compared with WT controls (Figure 1,
A and B). The kidney function assessed by measuring se-
rum urea and urine protein levels confirmed the histological
observations showing significantly increased serum urea
and proteinuria in Jund-/- animals (Figure 1, D and E). We
also assessed serum albumin levels and demonstrated re-
duced serum albumin in Jund-/- animals when compared with
WT littermates, consistent with the increased albuminuria (Fig-
ure 1F). Glomerular CD68 and CD4 cell infiltration showed
increased infiltration of positive cells for these markers in the
Jund-/- mice when compared with WT littermates (Figure 1G).
Deposited Glomerular IgG and Humoral
Immune Response Assessment
Quantitation of sheep IgG deposited on the glomerular
basement membrane on day 10 showed no significant
difference between Jund-/- and WT littermates (Figure 2,
A and C). In addition, as a measure of humoral immune
response, glomerular mouse IgG was also quantified on
frozen kidney sections and no significant difference was
found between the Jund-/- and WT mice (Figure 2, B and
C). Serum levels of mouse total IgG specific for sheep
IgG were also assessed (Figure 2D) and showed no
significant differences between the two groups of mice.
Serum levels of IgG subclasses (IgG1, IgG2a, IgG2b,
and IgG3) were analyzed by enzyme-linked immunosor-
bent assay, and we did not find any significantly different
levels of these antibodies in the serum samples of Jund-/-mice and WT littermates on day 10 after the induction ofthe accelerated NTNmice and WT littermates on day 10
after the induction of the accelerated NTN (see Supple-
mental Figure S1 at http://ajp.amjpathol.org). In addition,
we assessed the C3 deposition in the glomeruli of Jund-/-
and WT mice on day 10 after NTN induction and did not
find any significant difference in the intensity of C3 stain-
ing in glomeruli between the two groups (data not
shown). Splenocyte proliferation to sheep IgG was deter-
mined after preimmunization. There was no significant
difference in splenocyte proliferation to antigen between
the WT and Jund-/- mice (see Supplemental Figure S2 at
http://ajp.amjpathol.org). Taken together, these results
show clearly that the increased susceptibility of the
Jund-/- mice to accelerated NTN is independent of the
glomerular deposition of the nephrotoxic antibodies and
the immune response against the implanted sheep IgG in
the glomeruli.
Jund Expression Is Restricted to Glomerular
Podocytes
Given that Jund-targeted deletion was achieved by replace-
Figure 1. Targeted deletion of Jund leads to severe Crgn in mice. Severity of
glomerular injury (scored by assessing glomerular hypercellularity and cres-
cents on a semiquantitative scale, where 0 represents normal) (A), percent-
age of glomerular crescents (B), and representative H&E-stained glomeruli
(C) showing crescent formation in the Jund -/- mice (day 10 after NTS injec-
tion). Serum urea (D) and proteinuria (E) levels are significantly increased in
Jund -/- animals compared with WT controls 10 days after the injection of
NTS. The kidney function assessed by measuring serum albumin also
showed a significant reduction in serum albumin in Jund -/- animals when
compared with WT controls (F). The numbers of CD68 and CD4 cells per
glomerular cross section (gcs) were also significantly increased in the Jund -/-
mice when compared with WT controls (G). Ten mice were used for all of the
parameters, except for proteinuria (six mice used). ***P  0.001.ment of Jund with LacZ,15 the site Jund expression was
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normal and nephritic kidney sections. Jund promoter is
markedly active in glomerular podocytes in the basal and
nephritic glomeruli 10 days after the induction of acceler-
ated NTN (Figure 3). Given the previously established role
of Jund in regulating oxidative stress and angiogenesis,3,6 we
hypothesized that the absence of Jund causes enhanced ox-
idative stress characterized by up-regulation of hypoxia-re-
sponse downstream genes within the glomerulus.
Targeted Deletion of Jund and Glomerular
Expression of Hypoxia-Induced Genes
Glomeruli from basal and NTN-induced Jund-/- and WT
mice were analyzed for the expression of hypoxia-response
downstream genes by RT-qPCR. We showed increased
expression of Vegfa, Cxcr4, and Cxcl12, but not fibronectin,
in basal Jund-/- glomeruli when compared with WT controls
(Figure 4, A–D). NTN induction did not cause a significant
difference in the expression of these genes, except for
Cxcl12 and fibronectin mRNA levels, which decreased and
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Figure 2. Deposited glomerular IgG and humoral immune response assess-
ment in WT and Jund -/- mice 10 days after accelerated NTN induction.
Quantitative immunofluorescence for sheep IgG (A) and mouse IgG (B).
Representative glomeruli showing immunofluorescence for sheep and
mouse IgG 10 days after the induction of accelerated NTN (C). Serum levels
of mouse total IgG specific for sheep IgG (D). Ten mice were used in each
group. AFU indicates arbitrary fluorescence unit; AEU, arbitrary enzyme-
linked immunosorbent assay unit; ns, nonsignificant.
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Figure 3. The Jund promoter is active in glomerular podocytes. Jund ex-
pression was assessed by IHC staining of -galactosidase. The Jund promoter
is markedly active in glomerular podocytes in the basal and nephritic glom-
eruli 10 days after the induction of accelerated NTN. WT mice glomeruli were
used as a negative control of -galactosidase staining.increased, respectively, in the Jund-/- glomeruli when com-
pared with WT controls (Figure 4, C and D). Furthermore,
we assessed whether the targeted deletion of Jund had any
effect on the expression of other AP-1 members, such as
c-Jun and c-Fos (Figure 4, E and F). Both in basal and
nephritic glomeruli, the expression of c-Jun and c-Fos was
not different between the WT and Jund-/- individuals, sug-
gesting that targeted deletion of Jund had a direct effect on
the relative expression of hypoxia-induced genes.
Given the previously established role of Jund as a determi-
nant of macrophage activation,9 we investigated whether tar-
geted deletion of Jund had an effect on Fc receptor–depen-
dant and Fc receptor–independent macrophage activation.
We measured Fc receptor–mediated oxidative burst (Fc oxy-
BURST assay) and phagocytosis in WT and Jund-/- BMDMs
(see Supplemental Figure S3, A and B, at http://ajp.amjpathol
.org). In addition, we also measured Nos2, Tnfa, and Ccl2
expression in WT and Jund-/- BMDMs after stimulation with
lipopolysaccharide (see Supplemental Figure S3C at http://
ajp.amjpathol.org). The results show that the targeted deletion
of Jund did not have an effect on mouse BMDM activation.
JUND Expression Controls VEGFA and HIF1A
mRNA Levels in a Human Podocyte Cell Line
To examine the direct effect of JUND on the regulation of
expression of VEGFA and HIF1A, we used a conditionally
Figure 4. Targeted deletion of Jund and glomerular expression of hypoxia-
induced genes. Glomerular expression of Vegfa (A), Cxcr4 (B), Cxcl12 (C),
and fibronectin (D) in unmanipulated (basal) and NTN-induced (NTN) WT
and Jund-/- mice assessed by RT-qPCR. Targeted deletion of Jund did not
significantly affect the expression of other AP-1 members, such as c-Fos (E)
and c-Jun (F). Six mice were used in each group. ns indicates nonsignificant.
*P  0.05, **P  0.01.
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proliferate at 33°C; however, after transfer to the “nonper-
missive” environment (37°C), they enter growth arrest
and express markers of differentiated in vivo podocytes,
mimicking the podocyte maturation in vivo19 (Figure 5A).
We first showed that podocyte differentiation is associ-
ated with increased VEGFA expression. Interestingly, the
increased VEGFA expression in differentiated podocytes
was also associated with decreased JUND expression
when compared with undifferentiated cells (Figure 5B).
We then performed siRNA knockdown of JUND in the
human podocyte cell line and showed that JUND mRNA
knockdown is associated with increased VEGFA and
HIF1A in the same cells (Figure 5C).
Discussion
JunD is a ubiquitously expressed member of the AP-1
transcription factor. Initial studies in fibroblasts showed
its antiapoptotic and antimitogenic effects. In addition,
JunD is not regulated by immediate-early gene transcrip-
tional mechanisms. These previous studies2 suggest that
JunD is an “atypical” member of AP-1 that can act as an
activator or repressor of transcription of diverse cell type–
specific genes involved in oxidative stress, cell prolifera-
tion, and differentiation.
The role of the AP-1 transcription factor in glomerulo-
nephritis has been examined in several studies. In rats
with immune complex nephritis, nuclear staining for AP-1
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Figure 5. JUND knockdown in conditionally immortalized human podocyte
cell lines. The human podocyte cell line was incubated for 14 days at 37°C to
allow full differentiation and maturation. A: The difference in cell morpholog-
ical features between the undifferentiated (33°C, top) and differentiated (37°C,
bottom) podocytes is illustrated by light microscopy. B: VEGFA and JUND
expression assessed by RT-qPCR in undifferentiated and differentiated podo-
cytes. C: Knockdown with JUND siRNA (100 nmol/L) in differentiated podocytes
showed 80% knockdown compared with scrambled siRNA (control siRNA, 100
nmol/L) by RT-qPCR. Both VEGFA and HIF1A expression levels were signifi-
cantly increased when JUND expression was knockdown. *P 0.05, **P 0.01.in several glomerular and tubulointerstitial cells was pre-viously reported.20 In humans, tubular overactivation of
AP-1 was described as a marker of progressive renal
disease.21 Furthermore, c-Jun N-terminal kinase–medi-
ated c-Jun/AP-1 activation was also detected in nephritic
glomeruli of rats22; more recently, blockade of c-Jun N-
terminal kinase signaling provided marked protection
against the progression of crescentic anti–glomerular
basement membrane glomerulonephritis in WKY rats.23
Interestingly, a recent study24 also showed that the epi-
dermal loss of JunB leads to a systemic lupus erythem-
atosus phenotype characterized by glomerular changes,
such as mesangial hypercellularity with glomerular base-
ment membrane thickening and luminal obstruction by
hyaline immune complex deposits.
The role of JunD in immune response was first reported
by Meixner and colleagues.25 They showed that JunD
suppresses lymphocyte proliferation and has a negative
effect on helper T-cell differentiation.25 Previously, JunD
was identified as a determinant of macrophage activation
in the WKY NTN model.9 In this model, Crgn is induced
by injection of an NTS raised in rabbit without any preim-
munization. On day 10 after the NTS injection, the inbred
WKY rat gets severe glomerular crescent formation and
macrophage infiltration in response to the planted anti-
bodies on the glomerular basement membrane, whereas
the Lewis rat is entirely resistant to any glomerular inflam-
mation despite the similar deposition of nephrotoxic an-
tibodies.13 Jund is markedly overexpressed in WKY BMDMs
and nephritic glomeruli, and its cellular expression level
control macrophage activation in rats and humans.9
Based on these results, we decided to investigate the role of
targeted deletion of JunD inmouse NTN and showed herein
that Jund-/- mice are markedly susceptible to accelerated
NTN. In this model, we did not show any effect of the
complete deletion of JunD on macrophage infiltration; how-
ever, we found that the absence of JunD in podocytes
caused up-regulation of hypoxia-inducible gene targets.
However, we cannot exclude a potential role of JunD in the
regulation of oxidative stress in WKY rat podocytes. To
answer these points, we are generating a Jund-knockout
WKY rat to study the direct effect of the targeted deletion of
JunD in the macrophage-dependant WKY NTN model.
Despite the marked susceptibility to accelerate NTN of
the Jund-/- mice, the absence of any enhanced humoral
immune response led us to question where the JunD
promoter is active within the mice glomerulus. We clearly
showed that, in the Jund-/- mice, the Jund promoter reg-
ulating LacZ expression is active in the glomerular podo-
cytes. It is well documented that podocytes function as
vascular-supporting cells producing Vegfa, a potent proan-
giogenic factor.26 Tight regulation of Vegfa signaling and
dosage is required for development and maintenance of
kidney function by regulating podocyte-endothelial cross
talk in the glomerulus.26,27 For instance, local reduction of
VEGF within the kidney is sufficient to trigger the patho-
genesis of thrombotic microangiopathy.28 In addition, a
recent study29 identified VEGFA as a new susceptibility
locus for chronic kidney disease and kidney function in a
large genomewide association study. More importantly, a
previous study30 also showed the importance of Hif1a
stabilization due to podocyte-specific deletion of Vhlh
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stream genes, including Vegfa, causing rapidly progres-
sive glomerulonephritis in the mice. Based on the results
showing the accumulation of H2O2 in Jund
-/- cells caus-
ing the Hif1a accumulation and enhanced transcription of
Vegfa3,6 and CXCL12,7 we hypothesized that deletion of
JunD within the podocytes may cause oxidative stress
characterized by increased expression of hypoxia-induc-
ible genes, including Vegfa. Indeed, we showed in both
the glomeruli isolated from Jund-/- and WT mice and an
immortalized human podocyte cell line that JunD controls
VEGFA expression in podocytes. Our results confirm a
role for JunD in protecting the cells from oxidative stress
and emphasize the importance of podocyte biology in the
pathophysiological characteristics of Crgn.
In conclusion, the transcriptional mechanisms by
which JunD regulate Vegfa expression within the podo-
cytes require careful attention and JunD may be consid-
ered as a therapeutic target in glomerular diseases char-
acterized by altered Vegfa production.
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